Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology-Reference-Cited by-同舟云学术

Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology

Published:2023-04-01 Issue:2 Volume:29 Page:371-373
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Yoon Eileen Laurel,Jun Dae Won^ORCID

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://e-cmh.org/upload/pdf/cmh-2023-0086.pdf

Reference19 articles.

1. MAFLD: How is it different from NAFLD?

2. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

3. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

4. MAFLD Enhances Clinical Practice for Liver Disease in the Asia-Pacific region

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences;Clinical and Molecular Hepatology;2024-04-01

2. Waiting for the changes after the adoption of steatotic liver disease;Clinical and Molecular Hepatology;2023-10-01

3. Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”;Clinical and Molecular Hepatology;2023-01-01

4. The heated debate over NAFLD renaming: An ongoing saga;Hepatology Forum;2023